# IndeCon, Inc. – FDA Inspection, Dec 12, 2024

Source: https://www.keypedia.com/records/fda_inspections/indecon-inc/d75d58fc-1bd4-44ad-bbe6-a64f8feebaba
Source feed: FDA_Inspections

> FDA inspection 1256367 of IndeCon, Inc., December 12, 2024. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 1271. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1256367
- Company Name: IndeCon, Inc.
- Inspection Date: 2024-12-12
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Dallas District Office
- Citation Count: 3

## Related Documents

- [FDA Inspection 998132 - 2016-11-22](https://www.keypedia.com/records/fda_inspections/indecon-inc/81c813a0-59c5-4f9b-a601-bdf071cef1cf)
- [FDA Inspection 880573 - 2014-05-29](https://www.keypedia.com/records/fda_inspections/indecon-inc/d7e6e7b4-204c-4ccf-939f-20039f8ce5e7)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/elisa-m-fleming/bfb8308a-9b37-4051-90f2-66066c26e1f4)
- [Issuing Officer](https://www.keypedia.com/people/narning-v-briones/d3d10e10-2fd6-494e-974a-555d559b5001)
- [Investigator](https://www.keypedia.com/people/nerming-v-briones/b2d9e685-a627-4f9e-854c-0588865fd1b6)

Company: https://www.keypedia.com/companies/indecon-inc/4e69c625-7949-4a8f-8792-1c94387f1de7

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9
